Merck & Co.
Merck leans heavily on its oncology franchise Keytruda while building out newer vaccine and animal health businesses ahead of patent expiration.
Loading company analysis...
Independent equity research
Search thousands of US-listed stocks for live market and filing data. Covered companies also include Rithvik's complete written research.
Fresh research
Merck leans heavily on its oncology franchise Keytruda while building out newer vaccine and animal health businesses ahead of patent expiration.
Netflix has shifted from pure subscriber growth to monetizing its existing base through advertising, password sharing crackdowns, and price increases.
RTX combines commercial aerospace engines and parts with a large defense business, giving it exposure to both the travel recovery and global defense spending.
Goldman Sachs is a leading investment bank with strength in trading, advisory, and asset and wealth management, after scaling back its consumer banking push.
Philip Morris International is transitioning from traditional cigarettes toward smoke free products like IQOS and ZYN, which now drive a growing share of profit.
Palo Alto Networks is consolidating cybersecurity spend under its platform strategy, bundling network, cloud, and security operations tools into fewer vendor relationships.
The research standard
Every analysis connects the company behind the ticker to the forces that could shape its long-term value.
Start with how the company makes money and where its advantages come from.
Separate durable growth, competitive position, and catalysts from market noise.
Test the thesis against valuation, execution risk, and what could go wrong.